Cantor Fitzgerald analyst Charles Duncan reiterates Marinus Pharma (NASDAQ:MRNS) with a Overweight and maintains $28 price target.
Brunswick Corporation Reports Boston Whaler Recorded Record Sales During The Four-day Show With A 35% Increase In Revenue Vs. Last Year’s Event
Brunswick Corporation (NYSE:BC) today announced a record-breaking performance at the 2021 Fort Lauderdale International Boat Show (FLIBS) with record sales, units, and share gains from many of Brunswick’s
